A compound represented by Formula (III): or a pharmaceutically acceptable salt thereof, wherein: Y is absent, -CR b R b -, -O-, -NR b -, -S(O) n -; R 1 is phenyl, cyclopentyl, cyclohexyl, thienyl, pyridinyl, thiazolyl, pyrrolyl, imidazolyl, furanyl, oxazolyl, isoxazolyl, pyrazolyl, isothiazolyl, pyrimidinyl, pyrazinyl, pyridazinyl, oxadiazolyl, tetrahydropyranyl, triazolyl, or thiadiazolyl, each of which is optionally substituted with 1 to 3 groups individually represented by R a ; R 3 is monocyclic heterocyclyl or monocyclic heteroaryl, each of which is optionally substituted with 1 to 3 groups selected from -F, -CI, -Br, I, -CN, -NO 2 , -OR b , -(C 1 -C 4 )alkyl, -(C 1 -C 3 )alkylene-OR b , -(C 1 -C 3 )alkylene-NR b R b , -(C 1 -C 4 )haloalkyl, -(C 1 -C 4 )haloalkoxy, -(C 3 -C 8 )cycloalkyl, -NR b R b , -C(=O)NR b R b , -NR b (C=O)NR b R b , -S(O) n NR b R b , C(=O)OR b , -OC(=O)OR b , -S(O) n R b , -NR b S(O) n R b , -C(=S)OR b , -O(C=S)R b , -NR b C(=O)R b ,-C(=S)NR b R b , -NR b C(=S)R b , -NR b (C=O)OR b , -O(C=O)NR b R b , -NR b (C=S)OR b , O(C=S)NR b R b , -NR b (C=S)NR b R b , -C(=S)R b and -C(=O)R b ; each R 4 is independently selected from -F, -CI, -Br, I, -CN, -NR b R b , -OR b , -C 1 -C 4 alkyl, -(C 1 -C 3 )alkylene-OR b , -(C 1 -C 3 )alkylene-NR b R b , -C 1 -C 4 haloalkyl, and -C 1 -C 4 haloalkoxy; each R a is independently selected from -F, -CI, -Br, I, -CN, OR b , -(C 1 -C 4 )alkyl, -(C 2 -C 6 )alkenyl, -(C 2 -C 6 )alkynyl, -(C 1 -C 4 )haloalkyl, -(C 1 -C 4 )haloalkoxy, -(C 1 -C 3 )alkylene-OR b , and -(C 1 -C 3 )alkylene-NR b R b ; each R b is independently -H or -C 1 -C 4 alkyl; each m is independently 0, 1, 2, or 3; and each n is independently 0, 1, or 2. Y is absent, -CR b R b -, -O-, -NR b -, -S(O) n -; R 1 is phenyl, cyclopentyl, cyclohexyl, thienyl, pyridinyl, thiazolyl, pyrrolyl, imidazolyl, furanyl, oxazolyl, isoxazolyl, pyrazolyl, isothiazolyl, pyrimidinyl, pyrazinyl, pyridazinyl, oxadiazolyl, tetrahydropyranyl, triazolyl, or thiadiazolyl, each of which is optionally substituted with 1 to 3 groups individually represented by R a ; R 3 is monocyclic heterocyclyl or monocyclic heteroaryl, each of which is optionally substituted with 1 to 3 groups selected from -F, -CI, -Br, I, -CN, -NO 2 , -OR b , -(C 1 -C 4 )alkyl, -(C 1 -C 3 )alkylene-OR b , -(C 1 -C 3 )alkylene-NR b R b , -(C 1 -C 4 )haloalkyl, -(C 1 -C 4 )haloalkoxy, -(C 3 -C 8 )cycloalkyl, -NR b R b , -C(=O)NR b R b , -NR b (C=O)NR b R b , -S(O) n NR b R b , C(=O)OR b , -OC(=O)OR b , -S(O) n R b , -NR b S(O) n R b , -C(=S)OR b , -O(C=S)R b , -NR b C(=O)R b ,-C(=S)NR b R b , -NR b C(=S)R b , -NR b (C=O)OR b , -O(C=O)NR b R b , -NR b (C=S)OR b , O(C=S)NR b R b , -NR b (C=S)NR b R b , -C(=S)R b and -C(=O)R b ; each R 4 is independently selected from -F, -CI, -Br, I, -CN, -NR b R b , -OR b , -C 1 -C 4 alkyl, -(C 1 -C 3 )alkylene-OR b , -(C 1 -C 3 )alkylene-NR b R b , -C 1 -C 4 haloalkyl, and -C 1 -C 4 haloalkoxy; each R a is independently selected from -F, -CI, -Br, I, -CN, OR b , -(C 1 -C 4 )alkyl, -(C 2 -C 6 )alkenyl, -(C 2 -C 6 )alkynyl, -(C 1 -C 4 )haloalkyl, -(C 1 -C 4 )haloalkoxy, -(C 1 -C 3 )alkylene-OR b , and -(C 1 -C 3 )alkylene-NR b R b ; each R b is independently -H or -C 1 -C 4 alkyl; each m is independently 0, 1, 2, or 3; and each n is independently 0, 1, or 2. <EOS>